Pyrazinamide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Department Of State Health Services, Pharmacy Branch. The primary component is Pyrazinamide.
| Product ID | 55695-026_2b5aef5f-d967-55e0-e054-00144ff8d46c |
| NDC | 55695-026 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pyrazinamide |
| Generic Name | Pyrazinamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1995-04-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA081319 |
| Labeler Name | Department of State Health Services, Pharmacy Branch |
| Substance Name | PYRAZINAMIDE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Antimycobacterial [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 1995-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA081319 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1995-04-01 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PYRAZINAMIDE | 500 mg/1 |
| SPL SET ID: | 2b5aef5f-d966-55e0-e054-00144ff8d46c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0904-6696 | Pyrazinamide | Pyrazinamide |
| 10135-735 | PYRAZINAMIDE | pyrazinamide tablet |
| 33342-447 | Pyrazinamide | Pyrazinamide |
| 50090-0520 | Pyrazinamide | Pyrazinamide |
| 50090-0521 | Pyrazinamide | Pyrazinamide |
| 50090-5963 | Pyrazinamide | Pyrazinamide |
| 55695-026 | Pyrazinamide | Pyrazinamide |
| 60687-138 | Pyrazinamide | Pyrazinamide |
| 61748-012 | Pyrazinamide | Pyrazinamide |
| 67253-660 | Pyrazinamide | Pyrazinamide |
| 70518-0085 | Pyrazinamide | Pyrazinamide |
| 70518-2534 | Pyrazinamide | Pyrazinamide |
| 70954-484 | Pyrazinamide | Pyrazinamide |